Publications by authors named "Shatunov A"

Article Synopsis
  • Repeat expansions in the C9orf72 gene are a leading genetic cause of ALS and frontotemporal dementia, but understanding how this mutation causes neuron death is still unclear, complicating the search for effective therapies.
  • Researchers analyzed data from over 41,000 ALS and healthy samples to identify potential treatments, discovering that acamprosate, a drug used for other conditions, might be repurposed for C9orf72-related diseases.
  • Their findings demonstrated that acamprosate has neuroprotective properties in cell models and works similarly well as the current treatment, riluzole, showing the potential of using genomic data to find new drug applications.
View Article and Find Full Text PDF

The Siberian frog Rana amurensis has a uniquely high tolerance to hypoxia among amphibians, as it is able to withstand several months underwater with almost no oxygen (0.2 mg/liter) vs. several days for other studied species.

View Article and Find Full Text PDF

Background: The importance of thromboembolism in the pathogenesis of lacunar stroke (LS), resulting from cerebral small vessel disease (cSVD), is debated, and although antiplatelets are widely used in secondary prevention after LS, there is limited trial evidence from well-subtyped patients to support this approach. We sought to evaluate whether altered anticoagulation plays a causal role in LS and cSVD using 2-sample Mendelian randomization.

Methods: From a recent genome-wide association study (n=81 190), we used 119 genetic variants associated with venous thrombosis at genome-wide significance (<5*10) and with a linkage disequilibrium r<0.

View Article and Find Full Text PDF
Article Synopsis
  • Humans appear more prone to neurodegeneration than similarly aged primates, and it's unclear if this trait is unique to modern humans or shared with other hominids.
  • The study explored the potential impact of Neanderthal DNA on neurodegenerative disorders and examined the role of natural selection on genetic variants linked to these diseases using advanced statistical methods.
  • Findings indicated that there is no significant evidence that Neanderthal DNA or positively-selected genetic variants contribute to the genetic risk of Alzheimer's, ALS, or Parkinson's disease, helping to clarify the evolutionary background of these disorders in modern humans.
View Article and Find Full Text PDF
Article Synopsis
  • - Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease marked by the loss of motor neurons, often leading to death from respiratory failure within 3 to 5 years, with a significant genetic component influencing its risk.
  • - A study analyzed telomere length using genetic data from 6,195 ALS patients and controls, revealing that individuals with ALS had 20% longer telomeres compared to controls after adjusting for age and sex, and this finding was validated using brain samples.
  • - Interestingly, shorter telomeres were associated with a 10% increase in median survival among ALS patients, suggesting that telomere length may play a role in the disease's progression and overall survival chances.
View Article and Find Full Text PDF
Article Synopsis
  • * This study compares people with SOD1-related ALS to those without SOD1 variants, using extensive data from both groups to analyze age at symptom onset and survival time.
  • * Findings indicate that certain SOD1 variants are tied to younger ages of onset and unique survival patterns, suggesting that onset and survival can be independent in SOD1-ALS cases, highlighting the need for further research on rare variants.
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzes over 25,000 rare genetic variants in noncoding regions related to amyotrophic lateral sclerosis (ALS) using data from more than 6,000 ALS patients and over 70,000 controls.
  • - Researchers found that specific variants in the 3' untranslated region of the IL18RAP gene are more common in non-ALS individuals, significantly lowering their risk of developing ALS by five times.
  • - These IL18RAP variants enhance the survival of motor neurons by reducing neuroinflammation, highlighting the critical role of noncoding regions in genetic studies related to diseases like ALS.
View Article and Find Full Text PDF

There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability.

View Article and Find Full Text PDF
Article Synopsis
  • ALS is a life-threatening neurodegenerative disease affecting 1 in 350 individuals, and there is a significant need for treatments that modify the disease's progression.
  • A large genome-wide association study (GWAS) identified 15 genetic risk loci associated with ALS by analyzing data from nearly 30,000 ALS patients compared to over 122,000 controls.
  • The study highlights genetic connections to other neurodegenerative traits and concludes that high cholesterol levels may play a causal role in ALS, emphasizing disturbances in cellular transport and autophagy as key factors in the disease’s development in glutamatergic neurons.
View Article and Find Full Text PDF
Article Synopsis
  • - Evidence suggests that genetic variants identified in genome-wide studies can affect disease risk by impacting gene expression, particularly regarding Amyotrophic Lateral Sclerosis (ALS).
  • - Research utilized public data and Mendelian Randomization to establish that a specific gene significantly influences ALS risk through expression Quantitative Trait Loci (eQTL), revealing differences in gene expression in ALS patients compared to controls.
  • - Among the 20,757 genes examined, two key eQTLs, linked to known ALS genes, displayed significant differential expression and were found to affect survival rates in ALS patients, indicating their role as important regulatory elements in ALS pathology.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines how genetic factors influence DNA methylation (DNAm), which is crucial for understanding gene regulation and diseases, using data from 32,851 participants.
  • Researchers identified genetic variants linked to DNAm at over 420,000 sites and created a database of more than 270,000 independent mQTLs, highlighting the complexity and polygenic nature of DNAm levels.
  • The findings suggest that while some shared genetic variants are linked to both DNAm and complex diseases, only a few cases indicate a direct causal relationship, revealing a complicated connection between genetics and phenotypes.
View Article and Find Full Text PDF

Importance: Juvenile amyotrophic lateral sclerosis (ALS) is a rare form of ALS characterized by age of symptom onset less than 25 years and a variable presentation.

Objective: To identify the genetic variants associated with juvenile ALS.

Design, Setting, And Participants: In this multicenter family-based genetic study, trio whole-exome sequencing was performed to identify the disease-associated gene in a case series of unrelated patients diagnosed with juvenile ALS and severe growth retardation.

View Article and Find Full Text PDF

There is increasing evidence that endogenous retroviruses (ERVs) play a significant role in central nervous system diseases, including amyotrophic lateral sclerosis (ALS). Studies of ALS have consistently identified retroviral enzyme reverse transcriptase activity in patients. Evidence indicates that ERVs are the cause of reverse transcriptase activity in ALS, but it is currently unclear whether this is due to a specific ERV locus or a family of ERVs.

View Article and Find Full Text PDF

Background: People with neurodegenerative disorders show diverse clinical syndromes, genetic heterogeneity, and distinct brain pathological changes, but studies report overlap between these features. DNA methylation (DNAm) provides a way to explore this overlap and heterogeneity as it is determined by the combined effects of genetic variation and the environment. In this study, we aim to identify shared blood DNAm differences between controls and people with Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.

View Article and Find Full Text PDF

Illumina DNA methylation arrays are a widely used tool for performing genome-wide DNA methylation analyses. However, measurements obtained from these arrays may be affected by technical artefacts that result in spurious associations if left unchecked. Cross-reactivity represents one of the major challenges, meaning that probes may map to multiple regions in the genome.

View Article and Find Full Text PDF
Article Synopsis
  • * Additional gene-based analyses revealed links to several genes, including B4GALNT1 and TRIP11-ATXN3, and highlighted the role of ACSL5 and GPX3 in rapid weight loss, a common characteristic in ALS patients that can lead to shorter survival.
  • * Using data from 77 ALS patients and 77 controls, we found a trend indicating that certain genetic variants (SNPs) may impact fat-free mass in patients but not in controls, emphasizing the importance of lipid metabolism in understanding ALS
View Article and Find Full Text PDF

Objective: Smoking has been widely studied as a susceptibility factor for amyotrophic lateral sclerosis (ALS), but results are conflicting and at risk of confounding bias. We used the results of recently published large genome-wide association studies and Mendelian randomisation methods to reduce confounding to assess the relationship between smoking and ALS.

Methods: Two genome-wide association studies investigating lifetime smoking (n=463 003) and ever smoking (n=1 232 091) were identified and used to define instrumental variables for smoking.

View Article and Find Full Text PDF

To discover novel genes underlying amyotrophic lateral sclerosis (ALS), we aggregated exomes from 3,864 cases and 7,839 ancestry-matched controls. We observed a significant excess of rare protein-truncating variants among ALS cases, and these variants were concentrated in constrained genes. Through gene level analyses, we replicated known ALS genes including SOD1, NEK1 and FUS.

View Article and Find Full Text PDF

The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population. In most people, the repeat length is 2, but in people with ALS, hundreds to thousands of repeats may be observed. A small proportion of people have an intermediate expansion, of the order of 20 to 30 repeats in size, and it remains unknown whether intermediate expansions confer risk of ALS in the same way that massive expansions do.

View Article and Find Full Text PDF

A rare lysosomal disease resembling a mucopolysaccharidosis with unusual systemic features, including renal disease and platelet dysfunction, caused by the defect in a conserved region of the VPS33A gene on human chromosome 12q24.31, occurs in Yakuts-a nomadic Turkic ethnic group of Southern Siberia. VPS33A is a core component of the class C core vacuole/endosome tethering (CORVET) and the homotypic fusion and protein sorting (HOPS) complexes, which have essential functions in the endocytic pathway.

View Article and Find Full Text PDF